May 24,2024 | AIDEVI
Choosing between NMN 30000's higher concentration and NMN 18000's moderate dosage depends on individual health goals and preferences.
May 09,2024 | AIDEVI
Professor Michael Levitt, the 2013 Nobel laureate in Chemistry, was invited to become the chief scientific adviser for AIDEVI and discussed NMN18000's future plans in the Chinese market with the AIDEVI China team.